Why memory and concentration can change during the menopause transition, what emerging research says about follicle-stimulating hormone, and what the science does and does not mean for you.
You lose the word mid-sentence, and it does not come back to you until an hour later. You read the same paragraph three times and still cannot hold onto it. You walk into a room and suddenly cannot remember why you went there.
Maybe the feeling is not entirely unfamiliar. You remember being foggy after having a baby, during a stressful stretch at work, or at certain points in your cycle. But your youngest started kindergarten this year. Work is steady. And this is happening most days now, not some days.
So you wonder whether it is perimenopause, and you ask. Then the results come back and your estrogen and progesterone look normal, and you are holding two things that do not seem to fit: what the labs say, and what you are living.
Both are true. The hormone that shifts first in the menopause transition is usually not estrogen. It is follicle-stimulating hormone, or FSH, and it is rarely the one being measured.
Estrogen has long dominated the conversation about menopause and the brain, and for good reason. It is fundamental to brain health. But it may not tell the whole story, and it may not be the first chapter.
FSH is made by the pituitary gland, which sits at the base of your brain. It is named for what it does in the ovaries. As ovarian function changes with age, the exchange between the ovaries and the brain changes too, and FSH begins to rise. That rise can begin roughly six to ten years before your final period, often while estradiol is still fluctuating within its usual range.1
That timing alone made FSH interesting. Then came a finding that widened the question. Receptors that respond to FSH have been identified outside the ovaries, including in brain tissue. Most of that work has been done in animals, so we cannot assume the same holds in women. But it raised a question no one had thought to ask: what else is this hormone talking to?7,8
Figure 1. This chart helps explain one of the article’s key messages: FSH often begins rising years before the final menstrual period, while estradiol may still be fluctuating.
Does Brain Fog in Perimenopause Go Away?
For most women, the evidence is reassuring. Changes in learning, memory and concentration are commonly reported during the menopause transition. In the long-running Study of Women’s Health Across the Nation (SWAN) , women showed a temporary decline in learning during perimenopause, with performance rebounding to premenopausal levels afterward.2
That pattern is different from progressive cognitive decline. Forgetting a familiar word, losing your train of thought or having trouble concentrating during perimenopause does not, by itself, mean that something more serious is happening to your memory. Persistent or worsening cognitive changes should still be evaluated, but menopause-related brain fog generally follows a different pattern.
That is reassuring. The next question is why it happens at all, and for decades the answer has centered almost entirely on estrogen.
What We Already Know About Menopause and the Brain
Estrogen’s role in the brain is well established. It supports neuronal health, glucose metabolism in the brain and the connections between brain cells. As estrogen changes through the menopause transition, researchers can observe corresponding changes in brain structure, function and cognition.3,4,5
Brain health is also influenced by what is happening elsewhere in the body. Research has linked changes in blood sugar regulation, abdominal weight gain and cardiovascular risk with how processing speed and cognitive performance change through midlife, with blood pressure concerns appearing particularly relevant.6
Sleep and chronic stress matter as well. Together, these factors explain a great deal. They do not fully explain why cognitive changes can begin relatively early in the menopause transition, or why women of similar ages and health profiles can experience that transition so differently. FSH gives researchers another signal to consider.
What Does FSH Have to Do With the Brain?
Hormones are chemical messengers. They are produced in one part of the body and communicate with tissues that have receptors capable of receiving their signals. FSH is one of those messengers. As ovarian responsiveness changes during the menopause transition, the feedback between the ovaries, pituitary gland and brain changes, and circulating FSH rises.
Historically, that rise was read as a sign of declining ovarian function and little else. More recent research has broadened the question. FSH-responsive receptors have been reported in the hippocampus and the cerebral cortex, the regions you use to learn a name, hold a thought and find a word. In mouse models, those receptors have been found on the neurons themselves, which suggests FSH may act in the brain directly rather than only through its effects on estrogen.7,8
Animal research also suggests that FSH signaling may be involved in the maintenance work the brain depends on: neuroinflammatory balance, the strength of the connections between brain cells, how the brain handles fats, and how brain cells produce energy. These are the same processes involved in memory and clear thinking, which is why the receptor finding drew the attention it did.
What none of this establishes is cause. A receptor tells us a tissue can receive a signal. It does not tell us what that signal is doing in a woman’s brain, and no study has shown that FSH causes brain fog. What these findings give researchers is a reason to look, and a reason to look earlier than they have been.
There is no test to ask for here and no number to chase. What there is, for a great many women, is an explanation that has been missing. When your labs read normal and you feel the way you feel, nothing has been available to account for the gap, not to you and not to the person you asked. FSH has been rising the whole time. You have been reading your own body accurately, and the research is catching up to you.
“For decades we've viewed menopause through the lens of estrogen decline. However, researchers like Dr. Lisa Mosconi have begun to change that conversation. While estrogen remains fundamental to brain health, emerging science suggests we may be overlooking another important endocrine messenger. FSH may help us better understand when the brain begins adapting to midlife and why cognitive experiences vary so much from one woman to another.” — Dr. Deanna Minich
What Does Human Research on FSH and Brain Health Show?
Human research on FSH and brain health is still limited, and the distinction between association and causation matters.
In a brain imaging study of 191 women ages 40 to 65, the women with higher FSH performed no differently on cognitive testing. What did differ showed up on the scans: higher FSH was associated with more amyloid, a protein linked with Alzheimer's risk, and with lower gray matter volume in certain regions. The associations were strongest after menopause but were already detectable during perimenopause. They also held after researchers accounted for age, estradiol, hormone therapy use and APOE-4 status, a gene variant linked with higher risk of Alzheimer's later in life. In other words, the link between FSH and these brain changes was not simply explained by aging, estrogen levels or genetics.⁹
That gap matters. It raises the possibility that some physical brain changes may be detectable before noticeable cognitive symptoms appear.9
Figure 2. This graphic reinforces two important points at once: higher FSH was associated with certain brain-imaging changes, but cognitive performance did not differ.
Other human studies have reported associations between higher FSH and white matter changes or cognitive impairment, but findings have not been consistent across populations. Menopausal stage, estrogen levels, sleep, hot flashes, metabolic health and vascular risk all appear to influence the picture.10,11
Research attempting to explain possible mechanisms comes largely from animal studies. In mouse models, FSH signaling has been linked with pathways involved in neuroinflammation, synaptic function, and amyloid and tau accumulation. Whether these mechanisms operate the same way in women has not been established.8,12
For now, the most responsible interpretation is that FSH may be a marker of changes occurring during endocrine and brain aging. We do not yet know whether it contributes directly to those changes, accompanies them, or does some combination of both. This is also relevant after menopause: some of the strongest human associations between FSH and brain changes have been reported in postmenopausal women.11
What This Research Does and Does Not Mean for You
The newer FSH research is changing the questions scientists are asking. It does not yet give women a new brain-health diagnosis, treatment target or number to chase.
- There is no established FSH level that predicts whether you will experience brain fog.
- There is no established FSH threshold for brain health.
- A higher FSH level does not predict how an individual woman’s cognition will change over time.
- There is no human evidence showing that lowering FSH improves memory or cognition.
FSH can also fluctuate considerably during the menopause transition, which limits what a single measurement can tell you. For now, these findings are most useful for identifying patterns researchers can continue to study, rather than predicting what will happen to any one woman.
If FSH Is Not a Treatment Target, What Can Help Brain Fog Now?
The emerging FSH research does not yet give women a new treatment target. Its value may be in helping us recognize the endocrine transition earlier and understanding brain fog in a broader hormonal context. If FSH is changing before estradiol shows a sustained decline, it may help explain why some women notice cognitive changes before conventional hormone testing seems to tell the full story. For now, the actionable step is not necessarily to lower FSH. It is to use that earlier signal as a reason to pay closer attention to the factors already known to support cognitive health.
Start With Sleep, and Ask What Is Disrupting It
Sleep deserves particular attention because hormonal changes and sleep disturbance often overlap. In one study of midlife women, the association between higher FSH and white matter changes weakened after researchers accounted for sleep and hot flashes and night sweats.10
If night sweats are repeatedly waking you, the problem may not be poor sleep habits alone. Addressing what is disrupting sleep may be more useful than treating sleep as an isolated issue. Circadian timing and regularity may matter too, since melatonin patterns and circadian rhythms also change with age.13,14
Know Your Blood Pressure and Blood Sugar
The brain depends on healthy blood vessels and stable metabolic function. Blood pressure, blood glucose, how well your body handles blood sugar and body composition are relevant not only to cardiovascular health, but also to cognitive health. Midlife is therefore an important window for knowing those numbers and addressing risks early.6
Keep Moving
Both aerobic exercise and resistance training have been associated with cognitive benefits in midlife women. Exercise supports circulation and may influence brain-derived neurotrophic factor, or BDNF, which is involved in maintaining connections between brain cells and supporting memory.15,16
Look at the Overall Dietary Pattern
Dietary patterns associated with cardiovascular and metabolic health are also associated with brain health. The MIND diet, which draws from Mediterranean and DASH approaches, has been associated with better cognitive outcomes in middle-aged and older adults. Its emphasis includes vegetables, leafy greens, berries, nuts, beans, whole grains, olive oil and fish. The evidence points toward the overall pattern rather than one food acting as a solution.17
What About FSH and Mood?
Cognition is not the only reason researchers are looking at FSH in the brain. Early research is also examining pathways involved in mood and stress response.
In animal models, elevated FSH has been associated with changes in inflammatory signaling, synaptic function, glutamate and GABA activity. One of the studies involved male mice. That is a considerable distance from explaining mood changes in a woman going through perimenopause.12
For now, FSH and mood should be understood as an area being investigated, not an established explanation for menopausal mood changes.
When Brain Fog Deserves a Broader Look
Menopause is only one possible contributor to cognitive symptoms in midlife. If brain fog persists, worsens or begins affecting daily function, a broader evaluation can help identify other contributors.
Iron status is one consideration, particularly for women who are still menstruating and experiencing heavier periods. Low iron can contribute to fatigue and difficulty concentrating. Vitamin B12, folate and thyroid function can also affect cognition. Sleep disorders, medications and other health conditions may contribute as well.18,19
The goal is not to assume that every cognitive change at midlife is hormonal. It is to understand the menopause transition as one part of the larger clinical picture.
FSH Research Is Looking Beyond the Brain
The brain findings sit within a broader pattern in the FSH research. Receptors capable of responding to FSH have been identified in tissues beyond the ovaries, and researchers are examining FSH in relation to bone remodeling, body composition and metabolic health, vascular biology and the signaling between glands and the brain.21,22,23,24
The strength of the evidence is not the same in every system. In the current review, bone is the most developed area; vascular, metabolic and brain findings remain earlier and more mixed.24
That difference in evidence matters. FSH should not be treated as a single driver of all of these changes. A more useful way to read the research is that FSH may be one signal within a wider endocrine transition happening across several systems at once.
This is especially relevant to brain health because body fat, how the body handles fats, blood vessel health and low-level inflammation are themselves connected with cognitive aging. Some of the relationship between FSH and the brain may therefore be indirect, working through changes elsewhere in the body rather than through one isolated brain pathway.24
Figure 3. Simple systems map showing where FSH is currently being investigated beyond the ovaries. This figure also creates a natural bridge to related FSH articles on bone, metabolism/body composition and vascular health.
A Broader Way to Think About Menopause and the Brain
The emerging FSH research does not replace what we know about estrogen. It makes the picture more complete.
Menopause involves changing communication across the endocrine system. FSH is one signal within that system, and its rise begins relatively early in the transition. We do not yet know whether FSH will prove to be a regulator of brain aging, a useful biomarker, or primarily a signal that reflects broader endocrine adaptation.
What the research does support is a wider view of the menopause transition. The brain is not changing in isolation, and brain health cannot be separated neatly from sleep, metabolic health, cardiovascular health and the other physiological changes occurring at midlife. That broader view gives women a more useful framework for understanding what they are experiencing now, while the science continues to evolve.
Common Questions About Perimenopause Brain Fog and FSH
Is brain fog in perimenopause permanent? For most women, cognitive changes associated with the menopause transition appear to be temporary rather than progressive. The long-running SWAN study found that learning difficulties during perimenopause tended to rebound afterward. Persistent or worsening cognitive problems should still be evaluated.2
Does higher FSH predict future cognitive decline? No. Research has identified associations between higher FSH and certain brain-imaging changes across groups of women. That does not predict what will happen to an individual woman, and women with higher FSH in one important imaging study did not perform differently on cognitive testing.9
What does FSH have to do with the brain? FSH-responsive receptors have been reported in brain regions involved in learning and memory, particularly in preclinical research. This has led researchers to investigate whether FSH may have functions beyond reproduction.7,8
Should I have my FSH tested for brain fog? There is currently no established reason to test FSH specifically for brain health and no brain-health target value. FSH can also fluctuate during perimenopause, so a single result has limited meaning on its own.
Can poor sleep cause brain fog during menopause? Yes. Sleep disruption can affect memory, attention and mental clarity. Hot flashes and night sweats can also disrupt sleep, so hormonal changes and sleep-related brain fog may be connected.
Is FSH responsible for mood changes during perimenopause? We do not know. FSH-related mood research remains largely preclinical, so it should not currently be used to explain mood changes in individual women.12
Will hormone therapy improve my memory? The evidence on menopausal hormone therapy and cognition is mixed and individualized. Timing, formulation, age and health history all matter, so this is a discussion to have with a clinician who knows your medical history.
Does this research matter after menopause? Yes. Some of the strongest human associations between FSH and brain-imaging changes have been reported in postmenopausal women.
Where to Go Next
- The Hidden Intelligence Behind Your Hormones: How the Endocrine System Communicates
- The Whole Health Guide to Perimenopause
- Read the full review: Is Follicle-Stimulating Hormone (FSH) Misnamed?
About Dr. Deanna Minich
Dr. Deanna Minich, PhD, MS, CNS, FMCP, FACN, is Chief Science Officer at Symphony Natural Health. A nutrition scientist, researcher, educator and author with more than 25 years of experience across academia and the supplement industry, she is the lead author of Symphony’s recent scientific review examining the evolving role of follicle-stimulating hormone beyond reproduction. She has authored more than 50 scientific publications and seven consumer books and is the recipient of the 2025 Linus and Ava Helen Pauling Award.
Medically reviewed by
Emily Hernandez, MS, CNS, Science and Medical Team consultant at Symphony Natural Health. A board-certified nutrition specialist with a master's in nutrition education from American University, she practices functional and integrative nutrition with a clinical focus on hormonal health and healthy aging, and has presented her research at scientific conferences.
